CClinicalTrials.gg
Active, not recruitingNCT06633198Updated Jul 9, 2026

Heat, Microvascular Function and Aging

An Early Phase 1 interventional study of Passive Heating and L-NAME in Aging, sponsored by William Hughes. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-09.

Sponsored by William Hughes · Early Phase 1, Interventional, and Basic science

Phase
Early Phase 1
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Vascular dysfunction is a common factor in many chronic debilitating diseases, contributing to morbidity and mortality. With the onset of chronic disease or exposure to stress, the vasculature displays an inability to adequately respond to increased blood flow demands, manifesting in a reduced ability or altered mechanism of vasodilation. Aging is an independent risk factor in the development of cardiovascular disease, and reduces vasodilator capacity, or alters the mechanism by which vasodilation occurs in multiple vascular beds. Chronic exercise/physical activity is one of the most potent ways to enhance vascular function, resulting in favorable outcomes such as reductions in blood pressure, and improved ability to perform activities of daily living. Barriers to exercise or failure of long-term adherence preclude many populations from the cardiovascular benefits of exercise, thus further enhancing cardiovascular risk. Avenues to mimic blood flow patterns observed with exercise may exert beneficial effects without the need for the ability to exercise. Recent evidence has demonstrated that passive heat therapy, or chronic heat exposure (\~ +1°C in core temperature) results in reductions in major adverse cardiovascular events, blood pressure and improved large artery endothelial function, primarily through preservation of large artery function in response to vascular stress. It is unclear whether microvascular function is augmented in response to acute heat exposure, or whether this can protect against vascular insults particularly in older adults. Some preliminary evidence in humans suggest that autophagy, a cell recycling process is involved in the beneficial cardiovascular effects, as short-term heat exposure upregulates markers of autophagy. Previous evidence from our lab indicates that autophagy governs the mechanism by which microvascular vasodilation occurs. The role of autophagy in mediating the beneficial effects of passive heating is unknown.

02

Conditions studied

  • Aging

Keywords

  • Passive heating
  • Aging
  • Microvascular
  • Autophagy
03

In context

Lead sponsor

This is the only study on the registry with William Hughes as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Participants must be between 18-80 yrs. of age
  • No more than 1 cardiovascular risk factor (see list in exclusion criteria)

Exclusion criteria

Exclusion Criteria:

  • Cardiovascular Risk Factors
  • Uncontrolled/unmanaged hypertension and/or use of current anti-hypertensive therapy
  • Current Tobacco product use or within last 6 months
  • BMI greater than 30
  • Hyperlipidemia - diagnosed and/or taking medications to manage
  • Hypercholesterolemia - diagnosed and/or taking medications to manage (e.g. statins)
  • Type 1 or Type 2 Diabetes
  • Use of anti-coagulant or anti-platelet drugs
  • Use of beta blockers
  • Symptomatic coronary artery disease
  • Diagnosed Heart Failure (Any classification above Class I as defined by NY Heart Association)
  • Diagnosed renal impairment Renal impairment defined, according to National Kidney Foundation as abnormalities of kidney structure or function, present for greater than 3 months, including:
  • Albuminuria (ACR ≥ 30 mg/g)
  • Urine sediment abnormalities
  • Electrolyte and other abnormalities due to tubular disorders
  • Structural abnormalities detected by imaging
  • History of kidney transplantation
  • Decreased glomerular filtration rate (GFP \< 60 mL/min/1.73 m2)
  • Current Hormone Replacement Therapy Use
  • History of retinopathy
  • Documented neuromuscular disorders
  • Porphyria Cutanea Tarda (blistering of skin to sun; photosensitivity)
  • Pregnancy (Young Female subjects)
  • Allergies to povidone iodine
  • Tattoos on lower arm (forearm)
  • Use of erectile dysfunction medication in the past 6 months
  • Use of topical/non-topical steroids in last 6 months (e.g. cortisone cream)
  • Active anti-cancer treatment or treatment within last 12 months
  • Active COVID-19 or within the past 3 months
  • Gender Reassignment Therapy
05

Study design

Phase
Early Phase 1
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Passive Heating of lower limbs

    The lower limbs will be immersed in warm circulating water for 60 minutes.

    Procedure: Passive Heating · Drug: L-NAME

Interventions

  • ProcedurePassive Heating

    The lower limbs will be immersed in warm (42C) circulating water for 60 minutes.

  • DrugL-NAME

    L-NAME will be used during measurement of cutaneous microvascular function to test the dependency upon NO to elicit vasodilation.

06

What researchers measure

Primary outcomes

  1. Change in cutaneous microvascular function

    Change in cutaneous microvascular function assessed via microdialysis infusion of acetylcholine (dose response) in the presence and absence of L-NAME to test the dependency upon NO to elicit vasodilation.

    Time frame: Baseline, 60 minutes post I/R, and 60 minutes post hot water immersion + I/R injury

Secondary outcomes

  1. Spontaneous baroreflex sensitivity

    Change in spontaneous BRS

    Time frame: Baseline, 60 minutes post I/R, 60 minutes post hot water immersion + I/R injury

  2. 24-hour (Ambulatory) Blood Pressure

    Ambulatory blood pressure (systolic, diastolic) for both peripheral and aortic blood pressure

    Time frame: Baseline

  3. Change in plasma concentration of heat shock proteins

    Change in the plasma concentrations of various heat shock proteins (HSP 70, 90)

    Time frame: Baseline and 60 minutes post hot water immersion

07

Study locations

1 site
  • Medical College of Wisconsin
    Milwaukee, Wisconsin 53226, United States
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06633198
Lead sponsor
William Hughes
Responsible party
William Hughes (Assistant Professor, Medical College of Wisconsin) — Sponsor-investigator
First posted
Oct 9, 2024
Start date
May 1, 2025
Primary completion
Dec 31, 2028 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
Jul 9, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion